MXPA05010565A - Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado. - Google Patents
Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado.Info
- Publication number
- MXPA05010565A MXPA05010565A MXPA05010565A MXPA05010565A MXPA05010565A MX PA05010565 A MXPA05010565 A MX PA05010565A MX PA05010565 A MXPA05010565 A MX PA05010565A MX PA05010565 A MXPA05010565 A MX PA05010565A MX PA05010565 A MXPA05010565 A MX PA05010565A
- Authority
- MX
- Mexico
- Prior art keywords
- drug delivery
- delivery systems
- active ingredient
- encapsulated active
- encapsulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Physiology (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
Abstract
La presente invencion esta dirigida a sistemas de suministro de farmacos compuestos de un ingrediente activo encapsulado en una pelicula comestible en donde la pelicula comestible preferentemente sirve para administrar el activo al torrente sanguineo por via bucal; los sistemas de suministro de farmacos de la presente invencion son especialmente eficaces para administrar por via bucal un activo farmaceutico encapsulado, altamente eficaz para proporcionar beneficios de sedacion y/o de sueno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/405,420 US20040202698A1 (en) | 2003-04-02 | 2003-04-02 | Drug delivery systems comprising an encapsulated active ingredient |
PCT/US2004/009863 WO2004089336A2 (en) | 2003-04-02 | 2004-03-31 | Drug delivery systems comprising an encapsulated active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05010565A true MXPA05010565A (es) | 2005-11-23 |
Family
ID=33130486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05010565A MXPA05010565A (es) | 2003-04-02 | 2004-03-31 | Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040202698A1 (es) |
EP (1) | EP1608348A2 (es) |
JP (1) | JP2006521292A (es) |
CN (1) | CN1771026A (es) |
CA (1) | CA2521423A1 (es) |
MX (1) | MXPA05010565A (es) |
WO (1) | WO2004089336A2 (es) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050276836A1 (en) * | 1997-06-11 | 2005-12-15 | Michelle Wilson | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents |
US9561182B2 (en) * | 2003-08-22 | 2017-02-07 | Cure Pharmaceutical Corporation | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals |
US20040191302A1 (en) | 2003-03-28 | 2004-09-30 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
US8999372B2 (en) * | 2002-11-14 | 2015-04-07 | Cure Pharmaceutical Corporation | Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use |
US20040131662A1 (en) * | 2003-11-12 | 2004-07-08 | Davidson Robert S. | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
KR101128201B1 (ko) * | 2003-04-14 | 2012-03-23 | 에프엠씨 코포레이션 | 카파-2 카라기난을 함유하는 균질한 열가역성 젤 필름 및이로부터 제조된 연질 캡슐 |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
WO2005046363A2 (en) | 2003-11-07 | 2005-05-26 | U.S. Smokeless Tobacco Company | Tobacco compositions |
US20050238721A1 (en) * | 2004-04-07 | 2005-10-27 | Acquarulo Lawrence A Jr | One step compounding extrusion of drug filled polymers |
WO2005107811A2 (en) * | 2004-05-04 | 2005-11-17 | Perry Victor A | Drug delivery device |
US7959902B1 (en) * | 2004-09-21 | 2011-06-14 | Postlewaite Laura M | Device and method for treating the oral cavity |
AR051397A1 (es) * | 2004-10-21 | 2007-01-10 | Novartis Ag | Composicion farmaceutica |
US20070275135A1 (en) * | 2005-02-09 | 2007-11-29 | First Flavor, Inc. | Taste sampling process and product |
EP1695729A1 (en) * | 2005-02-25 | 2006-08-30 | Omron Healthcare Co., Ltd. | Medicament delivery device comprising a flexible bag |
US20060193896A1 (en) * | 2005-02-25 | 2006-08-31 | Cadbury Adams Usa Llc | Process for manufacturing a delivery system for active components as part of an edible composition |
US20070298061A1 (en) * | 2005-02-25 | 2007-12-27 | Cadbury Adams Usa Llc | Process for manufacturing a delivery system for active components as part of an edible compostion |
US20100233312A9 (en) * | 2005-04-11 | 2010-09-16 | The Procter & Gamble Company | Compositions comprising probiotic and sweetener components |
US9044049B2 (en) * | 2005-04-29 | 2015-06-02 | Philip Morris Usa Inc. | Tobacco pouch product |
CN101222861B (zh) | 2005-04-29 | 2010-09-08 | 菲利普莫里斯生产公司 | 袋装烟草产品 |
US20070020186A1 (en) * | 2005-07-22 | 2007-01-25 | Alpex Pharma S.A. | Solid dosage formulations of narcotic drugs having improved buccal adsorption |
US8685478B2 (en) | 2005-11-21 | 2014-04-01 | Philip Morris Usa Inc. | Flavor pouch |
JP4658222B2 (ja) * | 2006-06-28 | 2011-03-23 | キャドバリー・アダムズ・ユーエスエイ・エルエルシー | 食用組成物の一部分としての活性成分のための送達システムを製造するためのプロセス |
DE102006061287A1 (de) * | 2006-12-22 | 2008-06-26 | Lts Lohmann Therapie-Systeme Ag | Eßbare folienförmige Zubereitung mit Cola-Geschmack |
US20080166395A1 (en) * | 2007-01-04 | 2008-07-10 | Roush Steven H | Article for delivering substrates to the oral cavity |
US8616221B2 (en) | 2007-02-28 | 2013-12-31 | Philip Morris Usa Inc. | Oral pouch product with flavored wrapper |
US9888712B2 (en) | 2007-06-08 | 2018-02-13 | Philip Morris Usa Inc. | Oral pouch products including a liner and tobacco beads |
WO2009010881A2 (en) | 2007-07-16 | 2009-01-22 | Philip Morris Products S.A. | Oral pouch products with immobilized flavorant particles |
WO2009010884A2 (en) | 2007-07-16 | 2009-01-22 | Philip Morris Products S.A. | Tobacco-free oral flavor delivery pouch product |
US8950408B2 (en) | 2007-07-16 | 2015-02-10 | Philip Morris Usa Inc. | Oral pouch product having soft edge |
US8119173B2 (en) | 2007-07-16 | 2012-02-21 | Philip Morris Usa Inc. | Method of flavor encapsulation through the use of a drum coater |
ITMO20070323A1 (it) * | 2007-10-22 | 2009-04-23 | Illycaffe Spa | Contenitore |
JP4707770B2 (ja) * | 2008-04-07 | 2011-06-22 | 株式会社ツキオカ | 経口投与製剤 |
US8377215B2 (en) | 2008-12-18 | 2013-02-19 | Philip Morris Usa Inc. | Moist botanical pouch processing |
US9027567B2 (en) * | 2008-12-30 | 2015-05-12 | Philip Morris Usa Inc. | Oral pouch product with multi-layered pouch wrapper |
US8863755B2 (en) | 2009-02-27 | 2014-10-21 | Philip Morris Usa Inc. | Controlled flavor release tobacco pouch products and methods of making |
DK2436383T3 (en) * | 2009-05-29 | 2017-10-23 | Morishita Jintan Co | ORAL MEDICAL COMPOSITION AND ORAL MEDICAL Capsule WITH THE COMPOSITION CONCERNED |
WO2011012421A1 (en) | 2009-07-29 | 2011-02-03 | Unilever Nv | A dentifrice composition comprising polyethyleneglycol and a cooling agent |
US8747562B2 (en) | 2009-10-09 | 2014-06-10 | Philip Morris Usa Inc. | Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release |
TWI435733B (zh) | 2010-01-29 | 2014-05-01 | Colgate Palmolive Co | 用於口臭控制之口腔保健調配物 |
US20130052234A1 (en) * | 2011-08-25 | 2013-02-28 | Purebrands LLC | Edible strips |
CN104981483B (zh) * | 2012-08-24 | 2017-10-24 | 陶氏环球技术有限责任公司 | 新的羟烷基甲基醋酸琥珀酸纤维素 |
EP2801263B1 (de) * | 2013-05-09 | 2021-04-14 | Symrise AG | Verfahren zur Herstellung einer kühlende Zusammensetzung in Form eines Granulats |
KR101594592B1 (ko) * | 2013-07-18 | 2016-02-15 | 한국식품연구원 | 치아 미백용 조성물 |
EP3107940B1 (en) | 2014-02-20 | 2019-08-07 | Dow Global Technologies LLC | Novel esterified cellulose ethers of high molecular weight and homogeneity |
EP3337480A4 (en) * | 2015-08-17 | 2019-05-08 | Aequus Pharmaceuticals Inc. | TRANSDERMAL DELIVERY OF DOXYLAMINE SUCCINATE AND PIRIDOXINE HYDROCHLORIDE |
EP3548008A4 (en) * | 2016-11-30 | 2020-06-03 | Xeno Biosciences Inc. | PHARMACEUTICAL PREPARATIONS AND METHODS FOR WEIGHT MANAGEMENT AND MODULATION OF THE INTESTINAL MICROBIOTE |
CN107349114A (zh) * | 2017-07-19 | 2017-11-17 | 广州凯普秀科技有限公司 | 一种新型速溶牙齿护理微囊颗粒及其制备方法 |
GB2574878A (en) * | 2018-06-22 | 2019-12-25 | Biofilm Ltd | Oral compositions and mucoadhesive thin films formed therefrom |
GB2575625A (en) | 2018-06-22 | 2020-01-22 | Church & Dwight Co Inc | Oral care compositions comprising benzocaine and mucoadhesive thin films formed therefrom |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784390A (en) * | 1971-07-23 | 1974-01-08 | Hayashibara Biochem Lab | Shaped bodies of pullulan and their use |
US3972995A (en) * | 1975-04-14 | 1976-08-03 | American Home Products Corporation | Dosage form |
JPS60219238A (ja) * | 1984-04-14 | 1985-11-01 | Hayashibara Biochem Lab Inc | 徐崩性プルラン含有成形物とその製法 |
US6214378B1 (en) * | 1996-08-02 | 2001-04-10 | Hisamitsu Pharmaceutical Co., Inc. | Capsules for oral preparations and capsule preparations for oral administration |
US20010006677A1 (en) * | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
JP3449253B2 (ja) * | 1998-10-29 | 2003-09-22 | シオノギクオリカプス株式会社 | 硬質カプセルの製造方法 |
US6352719B1 (en) * | 1998-11-11 | 2002-03-05 | Bioprogress Technology International, Inc. | Capsule based drug delivery system |
DE19954245A1 (de) * | 1999-11-11 | 2001-07-19 | Lohmann Therapie Syst Lts | Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen |
US7067116B1 (en) * | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
DE10032456A1 (de) * | 2000-07-04 | 2002-01-31 | Lohmann Therapie Syst Lts | Schnell zerfallende Darreichungsform zur Freisetzung von Wirkstoffen im Mundraum oder in Körperhöhlen |
DE10107659B4 (de) * | 2001-02-19 | 2008-03-13 | Lts Lohmann Therapie-Systeme Ag | Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin |
US6419903B1 (en) * | 2001-08-20 | 2002-07-16 | Colgate Palmolive Company | Breath freshening film |
ITMI20022343A1 (it) * | 2002-11-05 | 2004-05-06 | Biofarm Srl | Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari. |
-
2003
- 2003-04-02 US US10/405,420 patent/US20040202698A1/en not_active Abandoned
-
2004
- 2004-03-31 EP EP04749580A patent/EP1608348A2/en not_active Withdrawn
- 2004-03-31 WO PCT/US2004/009863 patent/WO2004089336A2/en active Application Filing
- 2004-03-31 MX MXPA05010565A patent/MXPA05010565A/es not_active Application Discontinuation
- 2004-03-31 CN CNA2004800094465A patent/CN1771026A/zh active Pending
- 2004-03-31 JP JP2005518926A patent/JP2006521292A/ja active Pending
- 2004-03-31 CA CA002521423A patent/CA2521423A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2006521292A (ja) | 2006-09-21 |
CA2521423A1 (en) | 2004-10-21 |
US20040202698A1 (en) | 2004-10-14 |
EP1608348A2 (en) | 2005-12-28 |
WO2004089336A3 (en) | 2005-03-17 |
CN1771026A (zh) | 2006-05-10 |
WO2004089336A2 (en) | 2004-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05010565A (es) | Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado. | |
EA200401252A1 (ru) | Микрочастицы лекарственных веществ | |
MXPA04007980A (es) | Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea. | |
BRPI0406911A (pt) | Produto farmacêutico e/ou cosmético | |
FR11C0017I1 (es) | ||
WO2006124047A3 (en) | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent | |
AP1760A (en) | Platinum derivative pharmaceutical formulations. | |
EA200600696A1 (ru) | Фармацевтические композиции для предотвращения передозировки или неправильного употребления лекарственных средств | |
HUP0203590A2 (hu) | Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére | |
WO2006124681A3 (en) | Oral drug delivery system and methods of use thereof | |
MX2007005238A (es) | Una composicion veterinaria transmucosal que comprende detomidina. | |
WO2004080396A3 (en) | Liposomal curcumin for treatment of cancer | |
WO2004091591A3 (fr) | Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives | |
EA200600603A1 (ru) | Оральная система доставки лекарственного препарата | |
MXPA03002807A (es) | Estabilizacion de formulaciones solidas de farmacos. | |
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
IL179177A (en) | A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product | |
WO2005094790A8 (es) | Formulaciones liposomales | |
WO2003045305A3 (en) | Acetaminophen compositions | |
TW200509985A (en) | Drug delivery system for sub-Tenon administration of fine particles | |
WO2004087105A8 (en) | Combination formulations of platinum agents and fluoropyrimidines | |
EP1273301A3 (en) | Pharmaceutical preparations based on active ingredients susceptible to illict administration | |
MX2023005759A (es) | Composiciones y metodos para suministro de farmaco dermico profundo. | |
MY141008A (en) | Oral formulations of deoxypeganine and their uses | |
WO2004030684A3 (en) | Kavalactone product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |